MORE►
Eric Olson
Eric Olson, Ph.D. [Photo: UTSW]
UTSW Molecular Biologist Wins Prestigious Columbia Prize for Work on Duchenne Muscular Dystrophy
by Lance Murray | Sep 9, 2025
Eric Olson has spent decades dedicated to what he calls “the biggest prize of all”: a cure for the devastating disease. Nearly half of the scientists awarded Columbia’s Horwitz Prize over the past 58 years went on to win a Nobel, UTSW said.
by Lance Murray |
Jan 15, 2024
Molecular biologist Vincent Tagliabracci, who was named a Howard Hughes Medical Institute Investigator in 2021, will be honored by the Texas Academy of Medicine, Engineering, Science and Technology for his groundbreaking work on so-called zombie enzymes.
MORE►
by Lance Murray |
Dec 21, 2022
UT Southwestern researchers have used gene editing technology to develop what could be a breakthrough for dilated cardiomyopathy, a heart condition that affects one in 250 people worldwide.
“The pace of this field is really breathtaking,” said Eric Olson, Ph.D., who co-led the study. “I expect that if this moves forward into patients, we’re not talking within decades—we’re talking within years.”
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
